Skip to content

Forcyte Biotechnologies

YC W21 · Inactive · Discover drugs that control how much cells "squeeze" to treat disease

Competitors

Adjacent

Also from W21

All of W21

About Forcyte Biotechnologies

In a nutshell: many diseases are caused by how much your cells squeeze (asthma, fibrosis, others). We discover drugs that control how much cells squeeze, with ease, to treat disease. We use patented bioMEMS technology to turn cell strength (cells' ability to pull/ squeeze) into a quantifiable metric in drug discovery, to help find better drugs for mechanical diseases. We screen 100,000s of drugs against numerous contractile human cell types to comprehensively map human mechanobiology (the "contractome") and identify promising drug development starting points to deliver novel medicines to treat mechanically-driven diseases including asthma, hypertension, preterm labor, fibrosis, and others.

YC batch
W21 · Winter 2021
Status, per YC
Inactive
Category
Other
Team size
5
Location
Los Angeles, CA, USA
Checked
36m ago

YC tags: Drug discovery

Forcyte Biotechnologies in W21: 336 companies, 30% AI

Forcyte Biotechnologies: questions

Which YC batch was Forcyte Biotechnologies in?

Forcyte Biotechnologies was in Y Combinator's Winter 2021 batch (W21).

Is Forcyte Biotechnologies still active?

Y Combinator lists Forcyte Biotechnologies as inactive.

Where is Forcyte Biotechnologies based?

Forcyte Biotechnologies lists Los Angeles, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.